1 / 8

Safety of Ready to Use products

This document discusses the safety of Ready-to-Use Therapeutic Food (RUTF) and Ready-to-Use Supplementary Food (RUSF), focusing on the detection of Cronobacter Sakazakii and the risks it poses to the target population. The findings from a technical expert committee are presented, highlighting the need for more data and improvements in food safety practices. Next steps, including a manufacturer meeting and independent testing for salmonella, are outlined. Hazard identification for RUTF and RUF procurement is also discussed, along with UNICEF RUTF needs for 2013.

sonnier
Download Presentation

Safety of Ready to Use products

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Safety of Ready to Use products GNC Face to Face Meeting January 25, 2013

  2. Background • In July and September 2012 low level presence of Cronobacter Sakazakii was detected in RUSF and RUTF respectively through independent testing • Supplies were quarantined at country or manufacturer level • Final product certification of bacteria free product was required by manufacturers since January 2011 • UNICEF/WFP/MSF asked FAO and WHO to convene a technical expert committee to identify the actual risks to the target population • Lack of evidence regarding C.s, except for some studies in neonates

  3. Findings from committee • More data needed on the physiology of malnourished children • RUTF and RUFs considered in same category • Industry overall needs work to improve the food safety • Profile of hazards was re-worked and a new sampling protocol to address the revise hazards will be put forth by the committee • Cronobacter is NOT considered the biggest risk to the population • Salmonella is considered a larger risk

  4. Next steps • RUFs at country level will remain in quarantine until a final statement is officially released from the committee • Draft summary report is available and can be shared in the coming 3-4 weeks • Final statement from FAO/WHO (April?) • Manufacturer meeting (March 19th) organized by WFP/MSF/UNICEF to inform manufacturers in the change in testing • UNICEF will begin independent testing for salmonella with a more intensive sampling protocol (according to USFDA protocol for peanut butter)

  5. Hazard Identification for RUTF and RUF

  6. RUTF Procurement • Volume procured: 29,000 MT • Number of suppliers used: 19 • Portion sourced in Africa: 45% • Destination: 44 countries • Received in-kind: 1,200 MT (83% FFP)

  7. UNICEF RUTF needs for 2013 Forecast 1 (July/August 2012): • 32,000 MT (10,000 MT – from local sources) Forecast 2 (January 2013): • 34,000 MT

  8. Intended Use- at the OTP • RUTF used for children 6-59 months without medical complications for outpatient treatment • RUTF part of a clinical protocol whereby children repeated medical check-ups, antibiotics, de-worming, micronutrients • Mothers receive IYCF counselling • Children undergo an appetite test at each session to ensure that they have good appetite and they are observed while consuming RUTF

More Related